Week of 8/28/2022 Cannabis News: FBI says CBD off-limits for applicants, Cannarock coverage, and the DEA backs off psychedelic scheduling proposal
FBI noted online that applicants to join the FBI cannot have consumed cannabis including CBD for at least one year, Cannarock took place at Come and Take it Live in Austin, TX, and the DEA has backed off a proposal to place two psychedelic compounds in the Schedule 1 classification after two groups put up a challenge to the item. Read more of listen to the audio version if you are on the go.
Hemp confiscation shows disparities between law in Texas and enforcement.
What’s to stop law enforcement in Texas from confiscating your material and destroying it almost immediately? Apparently nothing in Texas. What is going on in Texas with major hemp haul road stops? Who has answers to resolves this issue?
US House passes marijuana research bill
On Wednesday, December 9, 2020, the US House passed H.R.3797 – Medical Marijuana Research Act. It will now move
SCOTUS denies hearing on marijuana case challenging DEA scheduling
In a blow to activists across the US, the Supreme Court (SCOTUS) declined to hear a case regarding the restrictive stance the
DEA relaxes rules for cannabis drug, descheduling it completely
On April 6th the DEA announced it was relaxing the rules on Epidiolex, making it no longer a scheduled substance. Epidiolex, derived from marijuana, is the only
Clearing confusion on the temporary DEA hemp rules suspension announced by USDA, TDA rule changes
Thursday afternoon the USDA announced a temporary removal of the rules requiring hot hemp crops to be disposed of via DEA methods, and drop the DEA accredited lab testing requirement.
Congressional Hearings Focus On Marijuana
The Energy and Commerce Subcommittee on Health met to discuss six cannabis reform proposals, which included two proposals that would federally legalize marijuana.
Three Federal Agencies Reviewing Public Comments on Marijuana, Hemp and Opioid Issues.
Three federal agencies—the Food and Drug Administration (FDA), the Environmental Protection Agency (EPA) and the Drug Enforcement Administration (DEA)—are now accepting comments from the public on cannabis-related topics such as […]